Dimerix Ltd (DXB)

Currency in AUD
0.253
-0.008(-2.88%)
Delayed Data·
Advertisement
DXB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.2500.265
52 wk Range
0.1580.665
Key Statistics
Bid/Ask
0.25 / 0.255
Prev. Close
0.26
Open
0.265
Day's Range
0.25-0.265
52 wk Range
0.158-0.665
Volume
970.23K
Average Volume (3m)
2.33M
1-Year Change
-46.7368%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DXB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Dimerix Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
26/08/2026
EPS / Forecast
-0.02 / --
Revenue / Forecast
4.24M / --
EPS Revisions
Last 90 days

Compare DXB to Peers and Sector

Metrics to compare
DXB
Peers
Sector
Relationship
P/E Ratio
−5.3x−3.5x−0.4x
PEG Ratio
0.050.000.00
Price/Book
−10.8x4.0x2.6x
Price / LTM Sales
25.0x14.4x3.0x
Upside (Analyst Target)
-134.8%51.3%
Fair Value Upside
Unlock−3.8%7.8%Unlock

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
13.51M2.25%3.78M
Other Institutional Investors
11.25M1.87%3.15M
Public Companies & Retail Investors
575.64M95.88%161.18M
Total
600.4M100.00%168.11M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Precision Funds Management Pty Ltd1.83%11,000,0003,080
Precision Opportunities Fund Ltd1.83%11,000,0003,080

FAQ

What Is the Dimerix (Sydney: DXB) Share Price Today?

The Dimerix stock price today is 0.253 AUD.

What Stock Exchange Does Dimerix (DXB) Trade On?

Dimerix is listed and trades on the Sydney Stock Exchange.

What Is the Ticker (Stock Symbol) for Dimerix?

The stock symbol (also called a 'ticker') for Dimerix is "DXB."

What Is the Current Dimerix Market Capitalisation?

As of today, Dimerix (Sydney: DXB) market cap is 151.900M AUD.

What Is Dimerix's (DXB) Earnings Per Share (TTM)?

The Dimerix EPS is currently -0.050 (Trailing Twelve Months).

Is DXB a Buy or Sell From a Technical Analyst Perspective?

Based on today's Dimerix moving averages and other technical indicators, the daily buy/sell signal for DXB stock is Strong Sell.

How Many Times Has Dimerix Stock Split?

Dimerix has split 9 times. (See the DXB stock split history page for full effective split date and price information.)

How Many Employees Does Dimerix Have?

Dimerix has 15 employees, based on their latest Companies House report.

What is the current trading status of Dimerix (Sydney: DXB)?

As of 10/09/2026, Dimerix (DXB) is trading at a share price of 0.253 AUD, with a previous close of 0.260 AUD. The stock has fluctuated within a day range of 0.250 AUD to 0.265 AUD, while its 52-week range spans from 0.158 AUD to 0.665 AUD.

What Is Dimerix (DXB) Price Target According to Analysts?

The average 12-month price target for Dimerix is 1.895 AUD, with a high estimate of 1.895 AUD and a low estimate of 1.895 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +649.01% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.